Abbott i-STAT 1 Manuel page 436

Références
1. D.S. Young, Effects of Drugs on Clinical Laboratory Tests, 3rd ed. (Washington, DC: American Asso-
ciation of Clinical Chemistry, 1990).
2. P.C. Painter, J.Y. Cope, J.L. Smith, "Reference Ranges, Table 41-20" in Tietz Textbook of
Clinical Chemistry—Second Edition, C.A. Burtis and E.R. Ashwood, eds. (Philadelphia: W.B.
Saunders Company, 1994).
3. CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. CLSI
document EP9-A [ISBN 1-56238-283-7]. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania
19087-1898, USA 1995.
4. P.J. Cornbleet and N. Gochman, "Incorrect Least-Squares Regression Coefficients in Method-Com-
parison Analysis," Clinical Chemistry 25:3, 432 (1979).
5. D.S. Young and E.W. Bermes, "Influence of Site Collection on Blood Gases and pH," in Tietz
Textbook of Clinical Chemistry—Second Edition, C.A. Burtis and E.R. Ashwood, eds.
(Philadelphia:W.B. Saunders Company, 1994).
6. Clinical and Laboratory Standards Institute (CLSI). Interference Testing in Clinical Chemistry; Ap-
proved Guideline-Second Edition. CLSI document EP7-A2 (ISBN 1-56238-584-4). Clinical and Laboratory
Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA 2005.
7. Hankins D.C, Kharasch E.D., Determination of the halothane metabolites trifluoroacetic acid and bro-
mide in plasma and urine by ion chromatography. J of Chromatography B. 692 (1997) 413-418.
8. Kharasch E.D, Hankins D., Mautz D., Thummel K.E. Identification of the enzyme responsible for oxida-
tive halothane metabolism: implications for prevention of halothane hepatitis. Lancet 1996; 347:1367-71.
9. Morrison J.E., Friesen R.H., Elevated serum bromide concentrations following repeated halothane
anaesthesia in a child. Can J Asaesth 1990; 37 (7): 801-803.
10. Wu, H.B. A., Tietz Clinical Guide to Laboratory Tests. 4th Edition. 2006.
11. Whillier S, Raftos JE, Chapman B, Kuchel PW. Role of N-acetylcysteine and cystine in glutathione
synthesis in human erythrocytes. Redox Rep. 2009;14(3):115-24.
12. Paolo Ventura, Rossana Panini, Maria CristinaPasini, Gabriella Scarpetta and Gianfranco Salvioli. N-
Acetyl-Cysteine Reduces Homocysteine Plasma Levels After Single Intravenous Administration by In-
creasing Thiols Urinary Excretion. Pharmacological Research. Volume 40, Issue 4, October 1999, Pages
345-350.
13. Charles R.A, Bee Y.M, Eng P.H.K., Goh S.Y. Point of care blood ketone testing: screening for diabetic
ketoacidosis at the emergency department. Singapore Med J 2007; 48 (11): 986.
14. Wendroth Scott M., Tiffany N. Heady, Doris M. Haverstick, Lorin M. Bachmann, Mitchell G. Scott,
James C. Boyd, and David E. Bruns. Falsely increased chloride and missed anion gap elevation during
treatment with sodium thiosulfate. Clinica Chimica Acta 2014; 431: 77–79.
15. Wu Alan H.B. Tietz Clinical Guide to Laboratory Tests (Fourth Edition). W.B. Saunders Elsevier (2006)
1024.
i-STAT est une marque déposée du groupe de sociétés Abbott dans plusieurs pays. Vacutainer est une marque déposée de Becton Dickinson and
Company, Franklin Lakes, NJ, Etats-Unis. LX20 est une marque déposée de Beckman Coulter Incorporated, Fullerton, CA, Etats-Unis. L'analyseur Bayer
860 est fabriqué par Bayer Diagnostics, Tarrytown, NY, Etats-Unis. Dimension RxL-Xpand est une marque déposée de Dade Behring Inc., Deerfield,
IL, Etats-Unis.
Abbott Point of Care Inc.
100 and 200 Abbott Park Road
Abbott Park, IL 60064 • USA
©2018 Abbott Point of Care Inc. All rights reserved. Printed in USA.
Glu - 6
Emergo Europe
Prinsessegracht 20
2514 AP The Hague
The Netherlands
Art: 714177-03S Rev. Date: 23-APR-18